Analyst Research: ACADIA Pharmaceuticals Inc (ACAD.O)

ACAD.O on Nasdaq

31.70USD
27 Jan 2015
Change (% chg)

$-0.58 (-1.80%)
Prev Close
$32.28
Open
$31.62
Day's High
$32.17
Day's Low
$31.61
Volume
1,647,464
Avg. Vol
1,248,785
52-wk High
$35.01
52-wk Low
$15.64

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - ACADIA PHARMACEUTICALS, INC. (ACAD-O) 4:44am EST Thomson Reuters Stock Report 11 25.00
ValuEngine Industry Report for Medical-biomed/genetics 26 Jan 2015 ValuEngine, Inc. 10 49.00
ACAD: Due Diligence Review: Forensic Earnings and Valuation 26 Jan 2015 New Constructs, LLC 9 25.00
"The Economy Matters" Report for ACAD: the economy's impact on ACAD's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score 26 Jan 2015 MacroRisk Analytics/EconomicInvestor 8 25.00
ValuEngine Rating and Forecast Report for ACAD 25 Jan 2015 ValuEngine, Inc. 11 25.00
ACADIA Pharmaceuticals 24 Jan 2015 S&P Capital IQ Quantitative Report 11 127.00
ACADIA Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 23 Jan 2015 Reuters Investment Profile 12 20.00
Value Graph: ACADIA PHARM -- ACAD 22 Jan 2015 Ford Investor Services, Inc. 1 12.00
TheStreet.com Ratings Stock Report For: ACADIA PHARMACEUTICALS INC (ACAD) 17 Jan 2015 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

Leslie Iversen

76 2000 Independent Chairman of the Board

Uli Hacksell

63 2014 President, Chief Executive Officer, Director

Stephen Davis

53 2014 Executive Vice President, Chief Financial Officer and Chief Business Officer

Roger Mills

56 2012 Executive Vice President - Development, Chief Medical Officer

Terrence Moore

59 2013 Executive Vice President, Chief Commercial Officer
Search Stocks